Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Adrenoleukodystrophy: full-pipeline trial registry
3 of 7 indexed Adrenoleukodystrophy trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Adrenoleukodystrophy: 7 US clinical trials tracked, 3 recruiting.
Adrenoleukodystrophy is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Masonic Cancer Center, University of Minnesota, running 2 of these trials.
Enrollment posture brief
Registry condition adrenoleukodystrophy
OPEN 3 | RECR 43% | LATE 2 | EARLY 3 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Solid Malignancies (43% recruiting · 7 trials)
Adrenoleukodystrophy lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Adrenoleukodystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Adrenoleukodystrophy is recruiting below its size-band peers.
3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Adrenoleukodystrophy research.
Masonic Cancer Center, University of Minnesota accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Adrenoleukodystrophy enrolment sits around 85 participants.
Median target enrolment is 85 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Adrenoleukodystrophy research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
The Myelin Disorders Biorepository Project
Children's Hospital of Philadelphia
NCT03047369
Adrenoleukodystrophy National Registry Study
Masonic Cancer Center, University of Minnesota
NCT03789721
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Joanne Kurtzberg, MD
NCT02254863
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Massachusetts General Hospital
NCT05003648
Stem Cell Transplant for Inborn Errors of Metabolism
Masonic Cancer Center, University of Minnesota
NCT00176904
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Mirum Pharmaceuticals
NCT00007020
Human Placental-Derived Stem Cell Transplantation
New York Medical College
NCT01586455
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Adrenoleukodystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Adrenoleukodystrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Adrenoleukodystrophy page
7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Adrenoleukodystrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Masonic Cancer Center, University of Minnesota sponsors the most Adrenoleukodystrophy trials on record, review their full trial history before evaluating a specific study. See Masonic Cancer Center, University of Minnesota's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adrenoleukodystrophy condition card totals 7 registered trials; most-linked intervention Cholic Acids; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.